Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-IL13&IL4, SAR156597 Vector   (CAT#: GTVCR-WQ2434MR)

This product GTVCR-WQ2434MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting IL13&IL4. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Chimeric; Humanized
RefSeq NM_001354991.2; NM_000589.4
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 3596; 3565
UniProt ID P35225; P05112
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-IL13&IL4, SAR156597 Vector (GTVCR-WQ2434MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ317MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL17A, AG1-25 Vector Vector AG1-25
GTVCR-WQ270MR IVTScrip™ pSP6-VEE-mRNA-Anti-BMP10&GDF2, ACE-041 Vector Vector ACE-041
GTVCR-WQ301MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL2RA, ADCT-301 Vector Vector ADCT-301
GTVCR-WQ873MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL13, CAT-354 Vector Vector CAT-354
GTVCR-WQ2370MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL6R, aIL6R88 Vector Vector aIL6R88
GTVCR-WQ2667MR IVTScrip™ pT7-VEE-mRNA-Anti-NGF, ZTS-00508841 Vector Vector ZTS-00508841
GTVCR-WQ1142MR IVTScrip™ pSP6-VEE-mRNA-Anti-ERBB2, DS-8201 Vector Vector DS-8201
GTVCR-WQ96MR IVTScrip™ pT7-VEE-mRNA-Anti-CD40, 4D11 Vector Vector 4D11
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.